Viewing StudyNCT05303129



Ignite Creation Date: 2024-05-06 @ 5:26 PM
Last Modification Date: 2024-10-26 @ 2:28 PM
Study NCT ID: NCT05303129
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-01-09
First Post: 2022-03-21

Brief Title: Prognostic Impact of the NeutrophilLymphocyte Ratio NLR in the Treatment of First-line Metastatic or Locally Advanced Breast Cancer Treated With CDK46 Inhibitor
Sponsor: Centre Francois Baclesse
Organization: Centre Francois Baclesse

Conditions & Keywords Data

Conditions:
Name
Metastatic Breast Cancer
Breast Cancer
Keywords:
Name View
NeutrophilLymphocyte ratio NLR View
CDK46 View
lymphocyte typing View